INMi001-A

Registration Summary:

A P E C

USH2A-RP-iPSC

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg Name	INMi001-A
Alternative name(s)	USH2A-RP-iPSC
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	14th September 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Institute for Neurosciences of Montpellier (INM)
External Databases
Cellosaurus	CVCL_UJ75
Wikidata	Q94317981
General Information
Publications	Sanjurjo-Soriano C et al. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa. Stem cell research. 2018 Dec;33:228-232. Erkilic N et al. A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells. 2019 Sep 11;8(9). Sanjurjo-Soriano C et al. Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles. Molecular therapy. Methods & clinical development. 2020 Jun 12;17:156-173. Liu X et al. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells. Genes. 2021 May 25;12(6). Hosseini Shabanan S et al. Stem cell transplantation as a progressing treatment for retinitis pigmentosa. Cell and tissue research. 2022 Feb;387(2):177-205. Zaw K et al. Pathogenesis and Treatment of Usher Syndrome Type IIA. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2022 Jul-Aug 01;11(4):369-379. Sanjurjo-Soriano C et al. Retinoic acid delays initial photoreceptor differentiation and results in a highly structured mature retinal organoid. Stem cell research & therapy. 2022 Sep 16;13(1):478.

hIPSC Derivation

General